Targeting the ACE2/Apelin signalling and miRNAs could lead to the development of a novel therapeutic approach for patients with hypertension and other vascular diseases related to cardiovascular remodeling.

  • Hypertension is a complex cardiovascular disease. Recent studies have demonstrated that there is a link between the ACE2/Apelin signalling and microRNAs (miRNAs) in the pathogenesis of hypertension.
  • Deregulation of miRNAs expression play role in the development of hypertension. Various miRNAs in vasculature play role in cell proliferation, differentiation, de-differentiation etc process. They have both positive and negative effects in the pathogenesis which provide novel pharmacological implications for the prevention and treatment of hypertension.
  • Inhibition of the ACE/Ang II/AT1R signalling has been regarded as important pharmacological tools to prevent and treat vascular diseases such as hypertension.

Fig above: Crosstalk between the ACE2/Apelin signaling and miRNAs in hypertension. {ACE: angiotensin converting enzyme; ACE2: angiotensin converting enzyme 2; Ang II: angiotensin; AT1R: angiotensin II type 1 receptor; miRNAs: microRNAs; FGF2: fibroblast growth factor 2; FGFR1: fibroblast growth factor receptor 1.}

However this is just a beginning to the understanding of this new pathway, corresponding targets and functional roles of the ACE2/Apelin-related miRNAs still need to be identified and validated.

Citation
Chen et al. The ACE2/Apelin Signaling, MicroRNAs, and Hypertension. International Journal of Hypertension. Volume 2015 (2015), Article ID 896861, 6 pages.
Reference
[/reference

Leave a Reply

Get DrBond

Stop Procrastinating. Start Bonding! Get the App on your phone to bond with the medical world, while on the go!
Apps StorePlay Store
What do you need help with?